Certification in Basic Cannabinoid Medicine

Learn about this program specifically designed for health care clinicians who recommend medical cannabis therapy to their patients.

Society of Cannabis Clinicians

The first and oldest U.S healthcare organization promoting the use of medical cannabis

SCC International Chapters

The Society of Cannabis Clinicians has three active chapters in Latin
America, Australia, and the UK with growing communities across the globe.

Who We Are

The SCC is a nonprofit educational and scientific society of healthcare professionals and allies dedicated to advancing research and disseminating knowledge about medical cannabis.

Read On

COURSES

The SCC is a trusted provider of medical cannabis education. In our Clinical Training Curriculum, widely respected experts explain the scientific rationale for cannabis as medicine and the most effective treatment strategies.

Take a look

Research Library

The SCC supports the practice of evidence-based cannabinoid medicine. All articles in the collection have been vetted to ensure only rigorous, unbiased, and non-commercialized studies are included.

Learn more

Did you miss the 2023 Medical Cannabis Conference? Catch the recording here

Certification

The SCC’s Basic Cannabinoid Medicine certification program is specifically designed for health care clinicians who recommend medical cannabis therapy to their patients. All levels of clinicians, from medical students to senior attending physicians and departmental chairs, to advanced practice nurses, to pharmacologists, and to healthcare instructors, will benefit from this five-course curriculum.

View Certification Details

COURSE OFFERINGS

The SCC’s new Clinical Training Curriculum offers education missing from most health professional schools and clinical programs. The curriculum brings hands-on practical guidance on how to develop personalized treatment regimens and more. Continuing education courses enable clinicians to stay up-to-date on emerging topics to ensure patients are receiving the best possible treatment. Scholarships are available, learn more here.

Explore the Courses

Course Packages

All modules also available for individual purchase

5 Course Package: Basics

This 5-course package covers the essential science on the endocannabinoid system, botany, pharmacology, laboratory analysis, and the dosage and delivery of medical cannabis.

Purchase

$229.00

12 Course Package: Basics + Clinical Courses

This 12-course package expands upon the knowledge from the Basic package, giving the user a deeper understanding of medical cannabis education that addresses specific clinical conditions.

Purchase

$499.00

Comprehensive Clinical Package

The full collection of all 23 modules in the SCC Clinical Training Courses spanning essential science to cannabis therapeutics in clinical practice for specific conditions.

Purchase

$899.00

Which option best describes you?

I am a student looking to continue my education in medical cannabis

Learn More

I represent a college or university looking to offer cannabis programs or courses

Learn More

Blog

NEWS Jul 9, 2023

The highs and the lows: Recreational marijuana laws and mental health treat...

NEWS Jun 17, 2023

Middle School Cannabis Curriculum...

NEWS Jun 15, 2023

Medical Cannabis Science & Therapeutics Masters Program Commencement C...

NEWS Apr 28, 2023

Antiviral activities of hemp cannabinoids...

View All Posts

Latest News

Behavioral Health, Misc, News

The highs and the lows: Recreational marijuana laws and mental health treatment

Recreational marijuana laws (RMLs) continue to grow in popularity, but the effects on mental health treatment are unclear. This paper uses an event-study within a difference-in-differences framework to study the short-run impact of state RMLs on admissions into mental health treatment facilities. The results indicate that shortly after a state adopts an RML, they experience a decrease in the average number of mental health treatment admissions. The findings are driven by white, Black, and Medicaid-funded admissions and are consistent for both male and female admissions. The results are robust to alternative specifications and sensitivity analysis.

News

Middle School Cannabis Curriculum

SCC Member, Dave Gordon MD, was recently invited to review a middle school cannabis curriculum. Read below to see how education for this population has evolved since the DARE Program days.

News

Medical Cannabis Science & Therapeutics Masters Program Commencement Ceremony

It is with great honor and pride that we share that our SCC Board Member, Dr. Patricia Frye, on the 17th of May 2023, gave…

Covid-19, Herpes, HIV / AIDS, Misc

Antiviral activities of hemp cannabinoids

Hemp is an understudied source of pharmacologically active compounds and many unique plant secondary metabolites including more than 100 cannabinoids. After years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV), and γ-herpes viruses. Mechanisms of action include inhibition of viral cell entry, inhibition of viral proteases, and stimulation of cellular innate immune responses. The anti-inflammatory properties of cannabinoids are also under investigation for mitigating the cytokine storm of COVID-19 and controlling chronic inflammation in people living with HIV. Retrospective clinical studies support antiviral activities of CBD, Δ9-THC, and cannabinoid mixtures as do some prospective clinical trials, but appropriately designed clinical trials of safety and efficacy of antiviral cannabinoids are urgently needed.

Covid-19, Misc

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed “long COVID” or post-acute sequela of COVID-19 (PASC), can implicate persistent neurological complications in up to one third of patients and present as fatigue, “brain fog”, headaches, cognitive impairment, dysautonomia, neuropsychiatric symptoms, anosmia, hypogeusia, and peripheral neuropathy. Pathogenic mechanisms of these symptoms of long COVID remain largely unclear; however, several hypotheses implicate both nervous system and systemic pathogenic mechanisms such as SARS-CoV2 viral persistence and neuroinvasion, abnormal immunological response, autoimmunity, coagulopathies, and endotheliopathy. Outside of the CNS, SARS-CoV-2 can invade the support and stem cells of the olfactory epithelium leading to persistent alterations to olfactory function. SARS-CoV-2 infection may induce abnormalities in innate and adaptive immunity including monocyte expansion, T-cell exhaustion, and prolonged cytokine release, which may cause neuroinflammatory responses and microglia activation, white matter abnormalities, and microvascular changes. Additionally, microvascular clot formation can occlude capillaries and endotheliopathy, due to SARS-CoV-2 protease activity and complement activation, can contribute to hypoxic neuronal injury and blood–brain barrier dysfunction, respectively. Current therapeutics target pathological mechanisms by employing antivirals, decreasing inflammation, and promoting olfactory epithelium regeneration. Thus, from laboratory evidence and clinical trials in the literature, we sought to synthesize the pathophysiological pathways underlying neurological symptoms of long COVID and potential therapeutics.

Covid-19, Misc

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Cannabidiol is showing promising results for the treatment of COVID-19, due to its capa- bility of acting on the unleashed cytokine storm, on the proteins necessary for both virus entry and replication and on the neurological consequences of patients who have been infected by the virus. Here, we summarize the latest knowledge regarding the advantages of using cannabinoids in the treatment of COVID-19.

1999

Year Founded

38 States

Members practice in

24 Countries

Our members represent

1000+ Articles

in the Research Library

5000

Healthcare Professionals in our Network

Certification in Basic Cannabinoid Medicine

Society of Cannabis Clinicians

SCC International Chapters

Who We Are

COURSES

Research Library

Did you miss the 2023 Medical Cannabis Conference? Catch the recording here

Certification

COURSE OFFERINGS

Course Packages

5 Course Package: Basics

12 Course Package: Basics + Clinical Courses

Comprehensive Clinical Package

Which option best describes you?

Blog

Latest News

The highs and the lows: Recreational marijuana laws and mental health treatment

Middle School Cannabis Curriculum

Medical Cannabis Science & Therapeutics Masters Program Commencement Ceremony

Antiviral activities of hemp cannabinoids

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Global Impact

Affiliates & Allies

BECOME A MEMBER

Get Involved

TAKE OUR COURSES